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Summary.-The concentrations of IgG in acidic and 3MKCl eluates of resected colonic
carcinomas and adjacent normal tissue were determined by radioimmunoassay.
The mean concentration of IgG was significantly higher in both acidic and KCI
eluates of primary Dukes Stage C tumours than Dukes Stage A tumours. These
results provide direct evidence for increased fixation of IgG in vivo by human colonic
cancers which had metastasized. Our results also raise the possibility that IgG is
more tightly bound to the Stage C tumours. It is likely that this tumour-associated
Ig represents antibody to tumour antigens or antigen-antibody complexes, bound to
Fc receptors in the tumour.
MANY OBSERVATIONS attest to the
immunogenic potential of malignant
tumours in experimental animals and man
(Old & Boyse, 1966; Perlmann et al.,
1977). The products of such immune re-
sponses, both antibodies and sensitized
lymphocytes, seem capable of damaging
tumour cells in defined experimental con-
ditions (Hellstrom et al., 1971; Scornik &
Klein, 1978). However, the significance of
such responses to host resistance to
tumour growth in vivo is still unclear, in
view of the potential of immune reactants
to enhance tumour growth (Prehn, 1972;
Shearer et al., 1973) and recent observa-
tions suggesting immunological recogni-
tion of autologous non-malignant cells
(Perlmann et al., 1977; Weksler et al.,
1978).
Previous studies have demonstrated
that IgG is associated with solid tumours
(Witz, 1977), that a proportion of these
IgG molecules are antibodies against
tumour antigens with cytotoxic potential
(Ran et al., 1976) and that such anti-
bodies can be recovered in acidic eluates
(Ehrlich & Witz, 1979; Moav&Witz, 1978).
Other reports have demonstrated that
tumour antigens can be eluted from cell
membranes with 3M KCI (Meltzer et al.,
1971; Pincus, 1976). While these immune
reactants seem important in influencing
tumour growth, most of the information
which has been used to develop our con-
cepts of tumour-host interactions come
from experiments in vitro under defined
conditions, or from experimental tumours
in animals.
Data published by Jzsak et al. (1974)
suggest that human tumours with the
greatest malignant potential tend to bind
more 1251 anti-IgG than less malignant
tumours. Tumour-associated immuno-
globulins can influence tumour behaviour
in various ways, but initially it would
seem appropriate to directly quantitate
immunoglobulins boundtohumantumours
in vivo and to correlate this with evidence
of tumour progression in vivo. The present
study was undertaken to (a) compare the
concentration ofIgG in eluates oflocalized
and disseminated tumours; (b) determine
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whether KCl eluates of cells previously
exposed to acidic buffers contained sub-
stantial amounts of IgG, presumably as
tightly bound complexes; (c) compare
the concentration of IgG in eluates of
tumour tissue and corresponding normal
tissue.
MATERIALS AND METHODS
Tissues used in these studies were obtained
atthetime ofsurgeryfrom unselected patients
with carcinomas ofthe colon. Blocks oftissue
were obtained from freshly resected tumours
and from corresponding normal-appearing
tissue from the edge ofthe resected specimens.
This consisted of mucosa and adjacent bowel
wall. The wet weight oftissue was determined
in each case, and was usually 1-5 g. Suspen-
sions were prepared by dicing the tissues
with scalpels in a buffer (pH 7.4) containing
Na2HPO4 (0-008M), NaH2PO4 (0-0015M) and
NaCl (0131M) (PBS). The suspensions were
washed x 3 in PBS.
The diced tissues were suspended in 5 ml
glycine HCI buffer (O 1M, pH 2.8) for30 minat
roo-m temperature. Thetubes were centrifuged
at 500 g for 10 min, the supernatant fluid was
removed and dialysed overnight against PBS.
The cells were washed with PBS and sus-
pended in 5 ml 3M KCI overnight at 4°C. The
tubes were then centrifuged at 500 g and the
supernatant fluid dialysed 1 b against 4
changes ofPBS.
An additional acidic eluate was obtained
from the last 6 tumours to be processed. After
exposure to the initial acidic buffer, the tissue
was divided into 2. The first aliquot was sus-
pended in 3M KCI as outlined previously. The
second aliquot was suspended for a second
time in glycine HCI buffer (pH 2.8) for 30
min. After centrifugation, the supernatant
fluid was dialysed against PBS and the cells
were suspended in 3M KCl in the same way
as the other aliquot. The protein concentra-
tion in each eluate was determined by the
Bio-Rad assay (Bio Rad Laboratories) using
bovine serum albumin (BSA) as a standard.
Aradioimmunoassay wasusedtoquantitate
IgG in the eluates. IgG was purified from
the serum ofa patient with multiple myeloma
with an IgG paraprotein, by ammonium
sulphate precipitation and DEAE-cellulose
column chromatography. A 10 ,ug aliquot was
labelled to a specific activity of 3-9 ,uCi/,ug
with 1251, using chloramine T as oxidant
(Greenwood et al., 1963). The labelled protein
was stored in BSA (30 mg/ml) at - 20°C.
Goat antiserum to human IgG was obtained
from Hyland Laboratories, Malton, Ontario.
After dialysis against PBS, the proteins in
the antiserum were complexed to CNBr-
activated sepharose beads (Pharmacia, Dor-
val, Quebec). Aliquots of 2 ng of 1251 IgG
in 50jul PBS containing 30 mg/ml BSA, were
added to 10,l aliquots of anti-IgG sepharose.
A binding curve was determined by using
doubling dilutions of anti-IgG sepharose
mixed with CNBr sepharose inactivated with
IM ethanolamine (pH 8.0). The anti-IgG
sepharose was suspended in the 1251 IgG for
1 h at 37°C, then washed x 3 in PBS. Radio-
activity bound to the sepharose pellets was
then determined in a gamma scintillation
spectrometer.
Dilutions ofanti-IgGsepharosegreaterthan
1:32 substantially reduced the binding of
1251 IgG, so a 1: 32 dilution was used in sub-
sequent inhibition assays. Twenty ,ul of an
IgG standard (Technicon International of
Canada Ltd) in duplicate, or triplicate 20,u1
aliquots of acidic or KCI eluates were added
to 10,ul aliquots of anti-IgG sepharose. The
tubes were held at 37°C for 30 min before
adding 50,ul 1251 IgG. After 2 h at 37°C the
sepharose was washed x 3 with PBS and the
radioactivity in the pellets determined.
Eluates with markedly inhibited binding of
the 1251 IgG were reassayed after suitable
dilution.
The extent of tumour spread was deter-
mined independently by reviewing the
records of the operation and the results of
pathological examination of the resected
specimens and regional lymph nodes. The
tumours were classified as proposed by Dukes
& Bussey (1958), as localized to the bowel
wall (A), local extension to involve the serosa
(B) or metastases to regional lymph nodes
(C). None ofthe cases studied had evidence of
distant metastases.
RESULTS
The mean concentrations of protein in
the acidic and KCI eluates are shown in
Table I. The protein concentrations in the
acidic eluates tended to decrease slightly
with increased tumour dissemination,
whereas the protein in the KCI eluates
increased slightly. However, the differ-
ences were not statistically significant.
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TABLE I.-Protein concentrations (mean mg/g tissue+s.d.) in eluates of resected colonic
carcinomas
Dukes' Stage A (n= 6) Dukes' Stage B (n= 12) Dukes' Stage C (n=9)
A A , K A
Acidic Acidic Acidic
Tissue eluate KCI eluate eluate KCl eluate eluate KCI eluate
Tumour 2 21+0 82 0 84+0 32 1b60+0 30 1-28+0 27 0 82+0 09 1P35+0 37
Normal 1 69+0-49 0-44+0 08 1.54+0 23 0-84+0 20 1P33+0 26 0-77+0 25
TABLE II.-IgG concentrations in eluates of resected colonic carcinomas
IgG (,ug/mg protein)
Differen-
Sex Site* tiationt
F
F
F
F
M
M
M
F
M
F
M
F
M
M
F
M
F
F
M
F
F
F
M
F
F
F
F
F
HF
R
C
AC
SC
R
DC
R
SC
R
SF
SC
SC
C
R
DC
C
C
DC
R
SC
HF
C
SC
C
C
C
SF
M
w
M
M
M
M
M
p
p
M
M
M
M
M
M
M
p
p
M
p
p
M
Tumour tissue Normal tissue
Acidic Acidic
eluate KCI eluate eluate KCI eluate
17
86
2*3
3-4
6
4-2
73
27-4+ 13-7
117
78
212
1000
30
12
286
3-6
74
4-9
33
509
196-6 + 84-8
190
133
208
80
160
100
265
91
560
198-5 + 49-5
23
ND
26
58
8
10
7
22-0 + 7-9
2-7
18
15
400
25
33
32
4
37
121
50
262
83-3 + 35-6
129
60
112
65
25
215
500
333
600
226-5+ 69
55
30
3-6
10
24
35
ND
26-3 + 7-6
37
16
18
195
96
51
6-7
5
37
106
10
183
63-4 + 19-4
162
56
92
10
9
113
187
25
133
87-4 + 22-1
14
ND
116
10
14
24
6-5
30-7+ 17-1
4
266
40
87
40
33
8
6
240
206
24
100
87-8 + 27-6
200
22
12
17
28
233
33
60
11
68-4 + 28-5
* C = caecum; AC =ascending colon; HF =hepatic flexure; SF =splenic flexure; DC =descending colon;
SC =sigmoid colon; R =rectum.
t W =well differentiated; M =moderately differentiated; P =poorly differentiated.
The concentrations of IgG expressed as
pg/mg protein are shown in Table II. The
values in both acidic and KCI eluates from
the tumour and normal tissues are shown
for each patient. The patients are divided
into 3 groups on the basis of Dukes'
staging. They are listed by increasing age,
and the mean and standard errors for the
IgG concentrations in the acidic eluates of
the Stage C tumours were significantly
higher than the Stage A tumours, by
Student's unpaired t test (P < 0-02).
Age
Stage A
56
64
71
74
74
77
80
Mean
Stage B
50
53
63
66
66
71
71
72
72
74
77
88
Mean
Stage C
59
64
67
68
73
77
78
86
94
Mean
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TABLE III.-IgG concentrations (,ug/g
tissue) in second eluates ofresected colonic
carctnomas
Tumour tissue
2nd
acidic KCI
Stage eluate eluate
B 2-7 47
B 640 478
C 13-6 95
C 106 159
C 215 369
C 182 636
Mean 193-2 297-3
Normal tissue
2nd
acidic KC1
eluate eluate
2 10
ND ND
15-6 26
86 48
2-6 5
15 22
24-2 22-2
T N T N T N
A B C
TUMOUR STAGE (Dukes' classification)
FIGURE. Mean IgG concentrations in eluates
of resected colonic carcinomas. T =tumour,
N =normal.
The mean concentration of IgG in the
KC1 eluates of Stage C tumours was also
significantly higher than in the Stage A
tumours (P < 0.05). The concentrations of
IgG in the eluates of normal portions of
Stage B and C tumours were slightly
higher than in Stage A tumours, but the
differences were not significant. The IgG
concentrations in the KC1 eluates of the
Stage C tumours were also significantly
greater than in the eluates from the
corresponding normal tissue (P < 0.05).
The results are similar when the IgG con-
centrations were expressed as ,g/g tissue.
There was no apparent relationship be-
tween the IgG concentration and age, sex,
site of the primary tumour or degree of
differentiation.
It was noted that the mean concentra-
tions of both protein and IgG were lower
in the KCl eluates than in the preceding
acidic eluates in the A and B tumours, but
not in the C tumours. This was further
investigated by treating identical aliquots
of tissue previously exposed to the acidic
buffer with either 3M KCl or a second
acidic buffer of glycine HC1. The IgG con-
centrations in these eluates were then
determined and are shown in Table III. In
all 4 Stage C tumours, the IgC concentra-
tions in the KCI eluates were higher than
in the second acidic eluates. There were
no consistent differences in the 2 Stage B
tumours nor in the eluates from corre-
sponding normal tissue. As yet, no second
acidic eluates have been obtained from
Stage A tumours. The concentrations of
IgG in the eluates from the tumour tissue
were considerably higher than in those
from the corresponding normal tissue, but
the differences were not statistically
significant.
DISCUSSION
Our results show significantly greater
concentrations of IgG in both acidic and
3M KCI eluates of primary colonic carcin-
omas with regional metastases (Dukes'
Stage 3) than in similar eluates oflocalized
cancers (Dukes' Stage A). Intermediate
levels were found in eluates of tumours
with local extension (Dukes' Stage B).
These differences did not reflect more
general differences in protein concentra-
tion, since the mean protein concentration
in the acidic eluates of the localized
tumours was greater than in those with
metastases. There were no significant
differences between the different stages in
the concentrations of IgG in eluates of
corresponding normal tissue, suggesting
that the differences in the tumour eluates
were related to the neoplastic state.
While many reports reveal the presence
of tumour-associated antigens in KCI
eluates, the presence of substantial
amounts of IgG in these eluates suggests
that in many cases tumour components
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with autoantigenic activity may be in the
form of complexes. The mean concentra-
tion of IgG in the KCl eluates from the
tumours with metastases, unlike the
localized tumours, was somewhat higher
than in the preceding acidic eluates. Since
3m KCl solubilizes cell-membrane antigens
(Pincus, 1976), it would seem capable of
dissociating tightly bound antibody from
the cells, presumably as complexes. This
raises the possibility that IgG is more
tightly bound to primary tumours with
metastases than to localized tumours, and
makes it less likely that it represents
irrelevant immunoglobulin. Preliminary
comparisons of IgG concentrations in
acidic and KCI eluates ofidentical aliquots
of cells showed higher concentrations in
the KCI eluates of metastatic tumours,
whereas the concentrations in the eluates
of the corresponding normal tissue were
essentially the same. However, as yet,
there are too few localized tumours to
determine whether there is a consistent
difference between the tumour stages in
this respect.
Our results also show generally higher
concentrations ofIgG in eluates oftumour
tissue than in eluates of adjacent normal
tissue. The difference was statistically
significant in the case of KCI eluates from
Class C tumours. This difference presum-
ably represents a more precise definition
of tumour-associated immunoglobulins
than the total immunoglobulin content of
tumours.
Previous reports are consistent with our
findings. Anti-tumourantibody orantigen-
antibody complexes are capable of block-
ing lymphocyte-mediated cytotoxicity,
and may enhance tumour growth (Witz,
1977). Jzsak et al. (1974) reported that 9/12
miscellaneous human tumours with high
malignant potential bound 1251-labelled
anti-human IgG, compared with 5/13
tumours with low malignant potential.
Vanky et al. (1975) also found that human
tumour cells coated with IgG were less
efficient in stimulating autologous lympho-
cytes than those with little IgG. Our
results provide direct evidence for the
correlation of tumour-associated immuno-
globulins and metastasis in carcinoma of
the colon.
Thenatureoftherelationship oftumour-
bound Ig to tumour stage remains to be
determined. One could postulate that
tumours with metastases had been present
for a longer time, with progressive accu-
mulation of Ig, since older tumours have
been observed to contain more Ig in
experimental animals (Witz et al., 1974).
However, the concept that tumours with
metastases are simply a later stage than
localized tumours may be an oversimplifi-
cation. Experimental tumours vary
greatly in their propensity to metastasize
and indeed, so do different cells within
the same tumour (Fidler & Kripke, 1977).
Therefore, it is not unreasonable to postu-
late that tumour spread and metastasis
may be associated with different properties
of the tumour cells, different host re-
sponses, or both (Sugarbaker, 1979). Our
results showing increased IgG in eluates
of metastasized tumours could be inter-
preted in several ways. It is possible that
the tumours with metastases have differ-
ent surface properties leading to increased
non-specific trapping of immunoglobulins,
though this seems unlikely.
Systematic differences in proteolytic
activity in different tumour stages could
lead to differential degradation of IgG in
the tumours (Keisari & Witz, 1973, 1978)
though we detected no proteolytic activity
in the eluates. Tumours with metastases
may contain a higher concentration of
antibodies to tumour antigens because of
increased numbers of affinity of antigenic
sites, or enhanced humoral immune re-
sponses in these patients. It may be rele-
vant that whilst binding of high concen-
trations of antibody may activate com-
plement and damage tumour cells, binding
of antibody without complement activa-
tion may stimulate tumour growth
(Shearer et al., 1973). Fab fragments of
IgG may bind to tumour cells and stimu-
late tumour growth, having lost the
capacity to activate complement (Chard
et al., 1967; Witz, 1977). It is possible that
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the IgG activity detected in our assays
represents antigenic fragments ratherthan
intact molecules.
It hasrecently been shown that tumours
contain Fc receptors for IgG which may be
on infiltrating host mononuclear cells
(Wesenberg, 1978). That a substantial
proportion of tumour-associated Ig is
associated with Fc receptors is suggested
by the observation of an inverse relation-
ship between the amount ofIgG on human
tumours and their Fc receptor activity,
and prolonged washing of the tumours
decreased surface Ig and increased Fc-
receptor activity (Tonder et al., 1976). Fc
receptors have much higher affinity for
antigen-antibody complexes or aggre-
gated Ig than for native Ig (Dickler, 1974).
Such complexes could form when there is
antigen shedding from the tumour, which
maybe associatedwithtumourprogression
(Currie & Alexander, 1974). Further,
blocking of cytotoxicity for tumour cells
by soluble factors is associated with anti-
gen-antibody complexes rather than with
free antigen or antibody (Sjogren et al.,
1972). It is also known that activation of
suppressor T cells requires binding of
antigen-antibody complexes to Fc re-
ceptors on these cells (Moretta et al., 1979).
It has been suggested that enhancement
of tumour growth as well as protection of
foetal growth during normal pregnancy
occurs through activation of suppressor
cells by this mechanism (Gleicher et al.,
1979). It has also been demonstrated that
2 murine tumour cell lines with high
metastatic activity contained a high per-
centage of Fc receptor-positive cells,
whereas a cell line with low metastatic
potential had a low percentage of Fc
receptor-positive cells (Schirrmacher &
Jacobs, 1979).
These observations, though preliminary,
may be relevant to our results demon-
strating differential in vivo trapping of
immunoglobulin by human colonic carcin-
omas.
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